Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “CNS 2a”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT02388295
What this trial is testing

AZD3241 PET MSA Trial, Phase 2, Randomized,12 Week Safety and Tolerability Trial With PET in MSA Patients

Who this might be right for
Multiple System Atrophy, MSA
AstraZeneca 59
Early research (Phase 1)Study completedNCT05882695
What this trial is testing

Study of SPG302 in Healthy Volunteers and ALS Participants

Who this might be right for
Amyotrophic Lateral Sclerosis
Spinogenix 88
Testing effectiveness (Phase 2)Temporarily pausedNCT03652805
What this trial is testing

IPL344 in the Treatment of ALS Patients

Who this might be right for
Amyotrophic Lateral Sclerosis
Immunity Pharma Ltd. 15
Testing effectiveness (Phase 2)Study completedNCT05032196
What this trial is testing

Study of WVE-003 in Patients With Huntington's Disease

Who this might be right for
Huntington Disease
Wave Life Sciences USA, Inc. 47
Testing effectiveness (Phase 2)Study completedNCT01028794
What this trial is testing

Autologous Bone Marrow Mononuclear Cell Transplantation for Stroke Patients

Who this might be right for
Cerebral EmbolismStroke
National Cerebral and Cardiovascular Center, Japan 12
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06870240
What this trial is testing

A Randomised, Double-blind, Placebo-controlled Phase 2a Pilot Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of ONP-002 in Adults With Mild Traumatic Brain Injury

Who this might be right for
Mild Traumatic Brain Injury, Concussion
Oragenics, Inc. 40
Testing effectiveness (Phase 2)Ended earlyNCT04798989
What this trial is testing

The Effects of CY6463 in Participants With Alzheimer's Disease With Vascular Pathology

Who this might be right for
Alzheimer's Disease With Vascular Pathology
Tisento Therapeutics 12
Testing effectiveness (Phase 2)Ended earlyNCT01310114
What this trial is testing

Study of Human Placenta-derived Cells (PDA001) to Evaluate the Safety and Effectiveness for Patients With Ischemic Stroke

Who this might be right for
Stroke, AcuteMiddle Cerebral Artery StrokePosterior Cerebral Artery Stroke
Celularity Incorporated 44
Testing effectiveness (Phase 2)Study completedNCT04322149
What this trial is testing

Multiple Doses of AT-1501-A201 in Adults With ALS

Who this might be right for
Amyotrophic Lateral Sclerosis
Anelixis Therapeutics, LLC 54
Testing effectiveness (Phase 2)Study completedNCT04993768
What this trial is testing

A Phase 2a Study of TPN-101 in Patients With Progressive Supranuclear Palsy (PSP)

Who this might be right for
Progressive Supranuclear Palsy
Transposon Therapeutics, Inc. 42
Testing effectiveness (Phase 2)Study completedNCT01035671
What this trial is testing

Safety and Efficacy Study of A0001 in Subjects With Friedreich's Ataxia

Who this might be right for
Friedreich's Ataxia
Penwest Pharmaceuticals Co. 42
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07205601
What this trial is testing

Study of Intracerebroventricular Injections of Autologous Adipose-Derived Stem Cells (RB-ADSCs) in Participants With Mild-Moderate Alzheimer's Disease

Who this might be right for
Alzheimer Disease
Regeneration Biomedical, Inc. 115
Very early researchLooking for participantsNCT06464367
What this trial is testing

Mechanistic Studies of Psilocybin in Headache Disorders

Who this might be right for
Migraine
Yale University 50
Testing effectiveness (Phase 2)Study completedNCT02302157
What this trial is testing

Dose Escalation Study of AST-OPC1 in Spinal Cord Injury

Who this might be right for
Cervical Spinal Cord InjurySpine InjurySpinal Cord Trauma
Lineage Cell Therapeutics, Inc. 25
Testing effectiveness (Phase 2)Study completedNCT02361242
What this trial is testing

24-week Open-label Extension Study Evaluating PXT00864 Effect in Mild AD Patients Further to PLEODIAL-I Completion

Who this might be right for
Alzheimer Disease
Pharnext S.C.A. 45
Testing effectiveness (Phase 2)Study completedNCT01014975
What this trial is testing

A Safety and Dose Finding Study of Plasmin (Human) Administered Into the Middle Cerebral Artery of Stroke Patients

Who this might be right for
Acute Ischemic Stroke
Grifols Therapeutics LLC 40
Testing effectiveness (Phase 2)Study completedNCT02361424
What this trial is testing

Pilot Study Assessing the Effects of PXT00864 in Patients With Mild Alzheimer Disease (AD)

Who this might be right for
Alzheimer Disease
Pharnext S.C.A. 47
Very early researchLooking for participantsNCT04123314
What this trial is testing

Psilocybin for Depression in People With Mild Cognitive Impairment or Early Alzheimer's Disease

Who this might be right for
Depressive SymptomsDepressionAlzheimer Disease+1 more
Johns Hopkins University 20
Testing effectiveness (Phase 2)Study completedNCT02260674
What this trial is testing

A Safety and Tolerability Study of JNJ-54861911 in Participants With Early Alzheimer's Disease

Who this might be right for
Alzheimer's Disease
Janssen Research & Development, LLC 114
Very early researchNot Yet RecruitingNCT07568366
What this trial is testing

AI in Endoscopic Transsphenoidal Surgery

Who this might be right for
Pituitary Adenoma
University College, London 30
Next Page